- call +1-201-465-4211
- email sales@mrinsights.biz
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Scope of the Report:
This report studies the Blood Stream Infection Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Stream Infection Testing market by product type and applications/end industries.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.
North America accounts for the largest market share of the global market owing to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities. It is followed by Europe in terms of market share. Asia Pacific is anticipated to hold the third largest market share owing to large population pool and poor hygienic sense. Latin America and Middle East & Africa are the silent contributors of the market.
The global Blood Stream Infection Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Stream Infection Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Market Segment by Applications, can be divided into
Hospitals
Independent Diagnostic Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Blood Stream Infection Testing Market Overview
1.1 Product Overview and Scope of Blood Stream Infection Testing
1.2 Classification of Blood Stream Infection Testing by Types
1.2.1 Global Blood Stream Infection Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Blood Stream Infection Testing Revenue Market Share by Types in 2017
1.2.3 Conventional Blood Culture Tests
1.2.4 PCR Methods
1.2.5 Nucleic Acid Testing
1.2.6 Mass Spectroscopy
1.2.7 Point of Care Testing
1.3 Global Blood Stream Infection Testing Market by Application
1.3.1 Global Blood Stream Infection Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Independent Diagnostic Centers
1.3.4 Others
1.4 Global Blood Stream Infection Testing Market by Regions
1.4.1 Global Blood Stream Infection Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Blood Stream Infection Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Blood Stream Infection Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Blood Stream Infection Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Blood Stream Infection Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Blood Stream Infection Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Blood Stream Infection Testing (2013-2023)
2 Manufacturers Profiles
2.1 BD
2.1.1 Business Overview
2.1.2 Blood Stream Infection Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BD Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 bioMérieux
2.2.1 Business Overview
2.2.2 Blood Stream Infection Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 bioMérieux Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cepheid
2.3.1 Business Overview
2.3.2 Blood Stream Infection Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cepheid Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche Diagnostics
2.4.1 Business Overview
2.4.2 Blood Stream Infection Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Diagnostics Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 IRIDICA
2.5.1 Business Overview
2.5.2 Blood Stream Infection Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 IRIDICA Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bruker
2.6.1 Business Overview
2.6.2 Blood Stream Infection Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bruker Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Nanosphere
2.7.1 Business Overview
2.7.2 Blood Stream Infection Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nanosphere Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Siemens
2.8.1 Business Overview
2.8.2 Blood Stream Infection Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Siemens Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 AdvanDX
2.9.1 Business Overview
2.9.2 Blood Stream Infection Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AdvanDX Blood Stream Infection Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Blood Stream Infection Testing Market Competition, by Players
3.1 Global Blood Stream Infection Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Blood Stream Infection Testing Players Market Share
3.2.2 Top 10 Blood Stream Infection Testing Players Market Share
3.3 Market Competition Trend
4 Global Blood Stream Infection Testing Market Size by Regions
4.1 Global Blood Stream Infection Testing Revenue and Market Share by Regions
4.2 North America Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
4.5 South America Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
5 North America Blood Stream Infection Testing Revenue by Countries
5.1 North America Blood Stream Infection Testing Revenue by Countries (2013-2018)
5.2 USA Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
6 Europe Blood Stream Infection Testing Revenue by Countries
6.1 Europe Blood Stream Infection Testing Revenue by Countries (2013-2018)
6.2 Germany Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
6.3 UK Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
6.4 France Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Blood Stream Infection Testing Revenue by Countries
7.1 Asia-Pacific Blood Stream Infection Testing Revenue by Countries (2013-2018)
7.2 China Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
7.5 India Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
8 South America Blood Stream Infection Testing Revenue by Countries
8.1 South America Blood Stream Infection Testing Revenue by Countries (2013-2018)
8.2 Brazil Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Blood Stream Infection Testing by Countries
9.1 Middle East and Africa Blood Stream Infection Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Blood Stream Infection Testing Revenue and Growth Rate (2013-2018)
10 Global Blood Stream Infection Testing Market Segment by Type
10.1 Global Blood Stream Infection Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Blood Stream Infection Testing Market Forecast by Type (2018-2023)
10.3 Conventional Blood Culture Tests Revenue Growth Rate (2013-2023)
10.4 PCR Methods Revenue Growth Rate (2013-2023)
10.5 Nucleic Acid Testing Revenue Growth Rate (2013-2023)
10.6 Mass Spectroscopy Revenue Growth Rate (2013-2023)
10.7 Point of Care Testing Revenue Growth Rate (2013-2023)
11 Global Blood Stream Infection Testing Market Segment by Application
11.1 Global Blood Stream Infection Testing Revenue Market Share by Application (2013-2018)
11.2 Blood Stream Infection Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Independent Diagnostic Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Blood Stream Infection Testing Market Size Forecast (2018-2023)
12.1 Global Blood Stream Infection Testing Market Size Forecast (2018-2023)
12.2 Global Blood Stream Infection Testing Market Forecast by Regions (2018-2023)
12.3 North America Blood Stream Infection Testing Revenue Market Forecast (2018-2023)
12.4 Europe Blood Stream Infection Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Blood Stream Infection Testing Revenue Market Forecast (2018-2023)
12.6 South America Blood Stream Infection Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Blood Stream Infection Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Blood Stream Infection Testing Picture
Table Product Specifications of Blood Stream Infection Testing
Table Global Blood Stream Infection Testing and Revenue (Millio
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
